In pancreatic cancer, intratumoral NK cells show downregulation of activating receptors such as DNAM-1 and NKp30 and increased expression of inhibitory ligands like PVR on tumor cells, impairing their function despite infiltration​ (39). The gene discussed is CD226; the disease is pancreatic neoplasm.